Liminal BioSciences Inc.

LMNL · NASDAQ
Analyze with AI
6/30/2023
3/31/2023
12/31/2022
9/30/2022
Assets
Cash & Equivalents$19,312$26,942$37,144$40,752
Short-Term Investments$0$0$0$0
Receivables$788$1,030$1,177$1,498
Inventory$0$0$0$0
Other Curr. Assets$0$0$2,997$2,061
Total Curr. Assets$25,639$34,164$41,318$44,311
Property Plant & Equip (Net)$1,222$1,383$5,490$5,651
Goodwill$0$0$0$0
Intangibles$788$1,030$3,240$1,498
Long-Term Investments$0$0$0$0
Tax Assets$168$168$168$454
Other NC Assets$357$280$243$181
Total NC Assets$6,159$5,002$9,141$9,600
Other Assets$0$0$0$0
Total Assets$31,798$39,166$50,459$53,911
Liabilities
Payables$0$0$3,403$0
Short-Term Debt$679$713$735$719
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,560$8,403$5,965$8,414
Total Curr. Liab.$9,239$9,116$10,103$9,133
LT Debt$528$644$752$845
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$556$344$3,396$3,518
Total NC Liab.$1,084$988$4,148$4,363
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$10,323$10,104$14,251$13,496
Equity
Pref Stock$0$0$0$0
Common Stock$981,162$979,849$979,849$979,849
Retained Earnings-$1,098,874-$1,089,733-$1,082,301-$1,078,057
AOCI-$3,172-$3,170-$3,169-$2,911
Other Equity$142,359$142,116$141,829$141,534
Total Equity$21,475$29,062$36,208$40,415
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$31,798$39,166$50,459$53,911
Net Debt-$18,105-$25,585-$35,657-$39,188